In this podcast, we'll be hearing about an exciting new event taking

In this podcast, we’ll explore two areas in the subspecialty of myopia: Aude Couturier will share her expertise in macular holes and Dr Yves Lachkar will discuss glaucoma in highly myopic patients. Chaired by David Gaucher and Jost Jonas

In this episode, Editor in Chief at Ophthalmologica, Professor Martin Zinkernagel discusses two featured papers from Euretina’s official journal. The first paper discussed covers choroiditis and the second covers effective treatment regimen in macular degeneration. Faculty are Dr Jeannette Ossewaarde-van Norel and Evianne de Groot (University Medical Center Utrecht) and Mathis Thibaud, Red Cross University Hospital, Lyon

In this episode, we explore how to diagnose and treat intraocular lymphoma with a panel of leading retinal surgeons and oncologists. Dr Hibba Quhill chairs the discussion with Professors Carlos Pavesio and Mandeep Sagoo from Moorfields Eye Hospital, London.

In this episode, we will hear all of the tips and tricks to success when looking to submit your research to Ophthalmologica.

Faculty: Martin Zinkernagel (Ophthalmologica editors) and Marco Casola (Karger).

Chaired by Jonathan McCrea

In this episode, Edoardo Midena (Italy) chairs a discussion with four leading experts in Diabetic Retinopathy from across the world: Jakob Grauslund (Denmark), Carol Cheung (Hong Kong), Enrico Borrelli (Italy) and Daniel Ting (Singapore)

In this episode, Siegfried Priglinger (Germany) and Roxane Hillier (UK) take a look at treatment for macula-off RRD. They're joined by David Yorston (Scotland) and Julian Klaas (Germany) and will ask - how do we best define "macula-off" and when should we start treatment?

Treating rare diseases can sometimes be challenging due a the lack of literature. In this episode, Carlos Pavesio (UK) asks leading experts Sara Touhami (France) and Moncef Khairallah (Tunisia) about their approaches to the diagnosis and treatment of Acute Retinal Necrosis (ARN).

In this podcast, David Steel tells Alistair Laidlaw what he's learned from zeroing in on individual patient data and how factors like posture and hole size affect his decision-making in the treatment of macular holes